Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Cirrhosis | 4 | 2023 | 1863 | 0.860 |
Why?
|
| Celiac Disease | 1 | 2023 | 785 | 0.530 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 147 | 0.530 |
Why?
|
| Apolipoproteins B | 1 | 2014 | 374 | 0.430 |
Why?
|
| Oligonucleotides | 1 | 2014 | 572 | 0.390 |
Why?
|
| Interferon-alpha | 2 | 2015 | 895 | 0.340 |
Why?
|
| End Stage Liver Disease | 3 | 2019 | 314 | 0.320 |
Why?
|
| Fatty Liver | 1 | 2014 | 727 | 0.320 |
Why?
|
| Liver | 4 | 2020 | 7474 | 0.310 |
Why?
|
| Hypercholesterolemia | 1 | 2014 | 1151 | 0.300 |
Why?
|
| Critical Illness | 1 | 2020 | 2670 | 0.300 |
Why?
|
| Anticholesteremic Agents | 1 | 2014 | 979 | 0.290 |
Why?
|
| Lypressin | 1 | 2016 | 24 | 0.280 |
Why?
|
| Hepatorenal Syndrome | 1 | 2016 | 61 | 0.260 |
Why?
|
| Esophageal Sphincter, Lower | 1 | 2005 | 20 | 0.260 |
Why?
|
| Hepatitis C, Chronic | 2 | 2015 | 1031 | 0.260 |
Why?
|
| Adenoma | 1 | 2016 | 2174 | 0.250 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 4253 | 0.250 |
Why?
|
| Esophageal Achalasia | 1 | 2005 | 91 | 0.240 |
Why?
|
| Albumins | 1 | 2016 | 569 | 0.220 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 1182 | 0.220 |
Why?
|
| Vasoconstrictor Agents | 1 | 2016 | 642 | 0.210 |
Why?
|
| Antiviral Agents | 3 | 2018 | 2987 | 0.210 |
Why?
|
| Telemedicine | 1 | 2019 | 2872 | 0.200 |
Why?
|
| Ribavirin | 2 | 2015 | 395 | 0.190 |
Why?
|
| Liver Failure, Acute | 1 | 2021 | 165 | 0.180 |
Why?
|
| Liver Transplantation | 3 | 2019 | 2119 | 0.170 |
Why?
|
| Liver Function Tests | 1 | 2020 | 528 | 0.170 |
Why?
|
| Esophageal Neoplasms | 1 | 2008 | 1583 | 0.160 |
Why?
|
| Cholangiocarcinoma | 1 | 2021 | 516 | 0.140 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2023 | 1130 | 0.140 |
Why?
|
| Serologic Tests | 1 | 2017 | 374 | 0.130 |
Why?
|
| Heredity | 1 | 2016 | 154 | 0.130 |
Why?
|
| Cryoglobulinemia | 1 | 2015 | 87 | 0.130 |
Why?
|
| Liver Diseases | 2 | 2020 | 1253 | 0.120 |
Why?
|
| Hepatitis B virus | 1 | 2017 | 513 | 0.120 |
Why?
|
| Middle Aged | 14 | 2023 | 213383 | 0.120 |
Why?
|
| Attitude | 1 | 2019 | 776 | 0.120 |
Why?
|
| Haploinsufficiency | 1 | 2016 | 328 | 0.120 |
Why?
|
| Palliative Care | 2 | 2019 | 3493 | 0.120 |
Why?
|
| Hepatitis B, Chronic | 1 | 2018 | 393 | 0.120 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2017 | 602 | 0.110 |
Why?
|
| Arthritis | 1 | 2018 | 659 | 0.110 |
Why?
|
| Hepatectomy | 1 | 2016 | 550 | 0.110 |
Why?
|
| Aging | 2 | 2008 | 8664 | 0.100 |
Why?
|
| Hepatitis B | 1 | 2017 | 695 | 0.100 |
Why?
|
| Gastrointestinal Tract | 1 | 2018 | 814 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 11725 | 0.100 |
Why?
|
| Advance Care Planning | 1 | 2019 | 662 | 0.100 |
Why?
|
| Mutation | 1 | 2016 | 29786 | 0.100 |
Why?
|
| Antirheumatic Agents | 2 | 2018 | 1339 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2008 | 6364 | 0.100 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 2214 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2020 | 3528 | 0.090 |
Why?
|
| Female | 16 | 2023 | 380194 | 0.090 |
Why?
|
| Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2011 | 96 | 0.090 |
Why?
|
| Ascites | 1 | 2011 | 344 | 0.080 |
Why?
|
| Pedigree | 1 | 2016 | 4644 | 0.080 |
Why?
|
| Sepsis | 1 | 2021 | 2593 | 0.080 |
Why?
|
| Fibrosis | 1 | 2014 | 2029 | 0.080 |
Why?
|
| Prognosis | 3 | 2020 | 29063 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2016 | 4186 | 0.070 |
Why?
|
| Drug Therapy, Combination | 2 | 2016 | 6489 | 0.070 |
Why?
|
| Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
| Humans | 20 | 2023 | 744343 | 0.070 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
| Triglycerides | 1 | 2014 | 2454 | 0.070 |
Why?
|
| Fatty Acids | 1 | 2014 | 1809 | 0.070 |
Why?
|
| Death | 1 | 2011 | 678 | 0.070 |
Why?
|
| United States | 5 | 2020 | 69872 | 0.070 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3229 | 0.070 |
Why?
|
| Peristalsis | 1 | 2005 | 60 | 0.060 |
Why?
|
| Biopsy | 2 | 2014 | 6756 | 0.060 |
Why?
|
| Male | 12 | 2020 | 350118 | 0.060 |
Why?
|
| Cholesterol, LDL | 1 | 2014 | 2356 | 0.060 |
Why?
|
| Retrospective Studies | 7 | 2023 | 77449 | 0.060 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 684 | 0.060 |
Why?
|
| Hepacivirus | 1 | 2011 | 1379 | 0.060 |
Why?
|
| Deglutition Disorders | 1 | 2008 | 605 | 0.050 |
Why?
|
| Manometry | 1 | 2005 | 445 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2017 | 3712 | 0.050 |
Why?
|
| Risk Factors | 4 | 2020 | 72290 | 0.050 |
Why?
|
| Kaplan-Meier Estimate | 2 | 2011 | 6538 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2011 | 2240 | 0.050 |
Why?
|
| Pressure | 1 | 2005 | 1203 | 0.050 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 2924 | 0.050 |
Why?
|
| Hepatitis C | 1 | 2011 | 1591 | 0.050 |
Why?
|
| Hospitalization | 1 | 2020 | 10262 | 0.050 |
Why?
|
| Canada | 1 | 2016 | 2065 | 0.050 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12959 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 6622 | 0.040 |
Why?
|
| Hepatitis B Antigens | 1 | 2017 | 40 | 0.040 |
Why?
|
| Phenotype | 1 | 2016 | 16365 | 0.040 |
Why?
|
| Disease Progression | 1 | 2014 | 13284 | 0.040 |
Why?
|
| Hepatitis B Antibodies | 1 | 2017 | 159 | 0.040 |
Why?
|
| Aged | 6 | 2019 | 163280 | 0.040 |
Why?
|
| Medication Adherence | 1 | 2008 | 2063 | 0.040 |
Why?
|
| Taiwan | 1 | 2017 | 496 | 0.040 |
Why?
|
| Adult | 8 | 2020 | 214055 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 15540 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2019 | 289 | 0.030 |
Why?
|
| Attitude of Health Personnel | 2 | 2020 | 3843 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12245 | 0.030 |
Why?
|
| Waiting Lists | 1 | 2019 | 692 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2019 | 53288 | 0.030 |
Why?
|
| Observer Variation | 1 | 2020 | 2593 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2008 | 11031 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15076 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 847 | 0.030 |
Why?
|
| Age Factors | 1 | 2008 | 18370 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 2959 | 0.020 |
Why?
|
| Diarrhea | 1 | 2018 | 1348 | 0.020 |
Why?
|
| Pancreatitis | 1 | 2018 | 1092 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2017 | 2225 | 0.020 |
Why?
|
| Kidney | 1 | 2016 | 7186 | 0.020 |
Why?
|
| Colitis | 1 | 2018 | 1170 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 25043 | 0.020 |
Why?
|
| Time Factors | 2 | 2019 | 40075 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3923 | 0.020 |
Why?
|
| Communication | 1 | 2019 | 3749 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3158 | 0.010 |
Why?
|
| Young Adult | 1 | 2008 | 56430 | 0.010 |
Why?
|
| Graft Survival | 1 | 2011 | 3737 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 63114 | 0.010 |
Why?
|
| Recurrence | 1 | 2011 | 8340 | 0.010 |
Why?
|
| Incidence | 1 | 2011 | 20947 | 0.010 |
Why?
|
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(59)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_